Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2002-05-02
2008-10-14
Duffy, Patricia A (Department: 1645)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S388100, C530S387700, C530S388150
Reexamination Certificate
active
07435798
ABSTRACT:
The present invention is directed to novel antibodies that bind to novel polypeptides encoded by nucleic acids that are differentially expressed in kidney, stomach, and melanoma tumors.
REFERENCES:
patent: 5546637 (1997-07-01), Jacobs
patent: 6025156 (2000-02-01), Gwynn et al.
patent: 6124433 (2000-09-01), Falb et al.
patent: 6156500 (2000-12-01), Falb
patent: 6162604 (2000-12-01), Jacob
patent: 6228582 (2001-05-01), Rodier et al.
patent: 6395306 (2002-05-01), Cui et al.
patent: 6414117 (2002-07-01), Levinson
patent: 6465185 (2002-10-01), Goldfine et al.
patent: 6498235 (2002-12-01), Sheppard et al.
patent: 6562343 (2003-05-01), Levinson
patent: 6645499 (2003-11-01), Lal et al.
patent: 6730502 (2004-05-01), Van Hijum et al.
patent: 6737522 (2004-05-01), Sundick et al.
patent: WO 97/38085 (1997-10-01), None
patent: 00/18904 (2000-04-01), None
Hu et al. (2003, Journal of Proteome Research 2:405-412).
Pennica et al (Proc. Nat. Acad. Sci, 95:14717-14722, 1998).
Haynes et al. (Electrophoresis, 19:1862-1871, 1998).
Konopka et al (PNAS 83:4049-52, 1986).
Lewin (Genes VI (1997) Chapter 29, pp. 847-848).
Gokman-Polar et al (Cancer Research 61:1375-1381, 2001).
Anderson et al , Electrophoresis, 18:533-537, 1997.
Chen et al (Molecular and Cellular Proteomics, 1:304-313, Apr. 2002).
Gronborg et al (Molecular and Cellular Proteomics, 2006 Abstract only).
Bendayan (J. Histochem. Cytochem. 1995; 43:881-886).
Bost et al. (Immunol. Invest. 1988; 17:577-586).
Harlow et al, Antibodies A Laboratory Manual, Cole Spring Harbor Laboratory, 1988, p. 76.
Lederman et al. (Molecular Immunology 28: 1171-1181, 1991).
Li et al. (PNAS 77: 3211-3214, 1980).
Herber et al eds, The Dictionary of Immunology, Fourth Edition, Academic Press, 1995, p. 147.
Klein et al Selection for Genes Encoding Secreted Proteins and ReceptorsProc Natl Acad Sci .93 7108-7113 (1996).
Alberts, et al. 1994,Molecular Biology of the Cell, 3rd Edition, pp. 403-404, 453. New York: Garland Publishing.
Alberts, et al. 2002.Molecular Biology of the Cell 4th Edition, pp. 302, 363-364, 379, 435. New York: Garland Publishing.
Allman, et al. 1996. BCL-6 expression during B-cell activation.Blood, 87(12):5257-5268.
Chen, et al. 2002. Discordant protein and mRNA expression in lung adenocarcinomas.Molecular&Cellular Proteomics 1.4, pp. 304-313.
Fessler, et al. 2002. A genomic and proteomic analysis of activation of the human neutrophil by lipopolysaccharide and its mediation by p38 mitogen-activated protein kinase.The Journal of Biological Chemistry, 277(35):31291-31302.
Fu, et al. 1996. Translational regulation of human p53 gene expression.The EMBO Journal, 15(16):4392-4401.
Gökmen-Polar, et al. 2001. Elevated protein kinase C βII is an early promotive event in colon carcinogenesis.Cancer Research, 61:1375-1381.
Grimaldi, et al. 1989. The t(5;14) chromosomal translocation in a case of acute lymphocytic leukemia joins the interleukin-3 gene to the immunoglobulin heavy chain gene.Blood, 73(8):2081-2085.
Gygi, et al. 1999. Correlation between protein and mRNA abundance in yeast.Molecular and Cellular Biology, 19(3):1720-1730.
Hanash, S. 2003. Making sense of microarray data to classify cancer.The Pharmacogenomics Journal, 3:308-311.
Hanash, S. Mar. 2005. Integrated global profiling of cancer.Nature Reviews, Applied Proteomics Collection, pp. 9-14.
Hancock, W. S. 2004. Do we have enough biomarkers?Journal of Proteome Research, 3(4):685.
Hanna, et al. Aug. 1999. HER-2
eu breast cancer predictive testing.Pathology Associates Medical Laboratories.
Haynes, et al. 1998. Proteome analysis: Biological assay or data archive?Electrophoresis, 19:1862-1871.
Hu, et al. 2003. Analysis of genomic and proteomic data using advanced literature mining.Journal of Proteome Research, 2:405-412.
Hyman, et al. 2002. Impact of DNA amplification on gene expression patterns in breast cancer.Cancer Research, 62:6240-6245.
Jang, et al. 1997. An examination of the effects of hypoxia, acidosis, and glucose starvation on the expression of metastatis-associated genes in murine tumor cells.Clin. Exp. Metastasis, 15(5):469-483. (Abstract).
Konopka, et al. 1986. Variable expression of the translocatedc-abloncogene in Philadelphia-chromosome-positive B-lymphoid cell lines from chronic myelogenous leukemia patients.Proc. Natl. Acad. Sci. USA, 83:4049-4052.
Lewin, B. 1994. Oncogenes: Gene expression and cancer, Chap. 39, pp. 1196-1201.Genes V. New York: Oxford University Press.
Lewin, B. 1997. Regulation of Transcription, Chap. 29, pp. 847-848.Genes VI. New York: Oxford University Press.
Meeker, et al. 1990. Activation of the interleukin-3 gene by chromosome translocation in acute lymphocytic leukemia with eosinophilia.Blood, 76(2):285-289.
Meric, et al. 2002. Translation initiation in cancer: A novel target for therapy.Molecular Cancer Therapeutics, 1:971-979.
Ohara, et al. 2001. Directional cDNA library construction assisted by the in vitro recombination reaction.Nucleic Acids Research, 29(4):e22 p. 1-8.
Ørntoft, et al. 2002. Genome-wide study of gene copy numbers, transcripts, and protein levels in pairs of non-invasive and invasive human transitional cell carcinomas.Molecular&Cellular Proteomics, 1:37-45.
Pollack, et al. 2002. Microarray analysis reveals a major direct role of DNA copy number alteraction in the transcriptional program of human breast tumors.PNAS, 99(20):12963-12968.
Powell, et al. 1998. Expression of cytochrome P4502E1 in human liver: Assessment by mRNA, genotype and phenotype.Pharmacogenetics, 8:411-421. (Abstract).
Singleton, et al. 1992. Clinical and pathologic significance in thec-erbB-2 (HER-2
eu) oncogene.Pathol. Annu., 1(27):165-190.
Tokunaga, et al. 2000. Application of quantitative RT-PCR using “TaqMan” technology to evaluate the expression of CK 18 mRNA in various cell lines.J. Exp. Clin. Cancer Res., 19(3):375-381.
Vallejo, et al. 2000. Evidence of tissue-specific, post-transcriptional regulation of NRF-2 expression.Biochimie, 82(12):1129-1133. (Abstract).
Wang, et al. 1996. mRNA Differential display: Application in the discovery of novel pharmacological targets.Trends Pharmacol. Sci., 17(8):276-279.
Zhigang, et al. 2004. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues and its potential role in prostate carcinogenesis and progression of prostate cancer.World Journal of Surgical Oncology, 2:13.
2002-2003 Catalog & Technical Reference, New England BioLabs, Inc., p. 122.
Abe, et al. “An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue.”Br J Cancer. Dec. 1, 2003;89(11):2104. (Abstract Only).
Alberts, et al. 1994.Molecular Biology of the Cell, 3rd Edition, pp. 1216-1217. New York: Garland Publishing.
Ando, et al. “Selective apoptosis of natural killer-cell tumours by l-asparaginase.”Br. J. Haematol.Sep. 2005;130(6):860. (Abstract Only).
Aust, et al. “Human thyroid carcinoma cell lines and normal thyrocytes: expression and regulation of matrix metalloproteinase-1 and tissue matrix metalloproteinase inhibitor-1 messenger-RNA and protein.”Thyroid. Oct. 1997;7(5):713. (Abstract Only).
Barnes, et al. “Expression of embryonic fibronectin isoform EIIIA parallels alpha-smooth muscle actin in maturing and diseased kidney.”J Histochem Cytochem.Jun. 1999;47(6):787 (Abstract Only).
Bea, et al. “BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas.”Cancer Res.Mar. 15, 2001;61(6):2409 (Abstract Only).
Blaschke, et al. “Rapid quantitation of proinflammatory and chemoattractant cytokine expression in small tissue samples and monocyte-derived dendritic cells: validation of a new real-time RT-PCR technology.”J Immunol Methods. Dec. 1, 2000;246(1-2):79 (Abstract Only).
Buckley, et al. “Butyrate-induced reversal of dexamethasone resistance in autonomous rat Nb2 lymphoma cells.” Apoptosis. 1997;2(6):518. (Abstract Only).
Caberlotto, et al. “Alterations in neuropeptide Y levels
Goddard Audrey
Godowski Paul J.
Grimaldi J. Christopher
Gurney Austin L.
Wood William I.
Barnes Elizabeth M.
Duffy Patricia A
Genentech Inc.
Knobbe Martens Olson & Bear LLP
Kresnak Mark T.
LandOfFree
Antibodies to a polypeptide encoded by a nucleic acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies to a polypeptide encoded by a nucleic acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to a polypeptide encoded by a nucleic acid... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4003825